Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2026-04-02 @ 10:19 PM
Study NCT ID:
NCT06883695
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-12
First Post:
2025-03-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SHR-3045-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None